Kidney Transplant News and Research

RSS
A kidney transplant is an operation where a healthy kidney from one person (the donor) is transferred to a person who has little or no kidney function (the recipient).
FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease

Concert Pharmaceuticals reports results from CTP-499 Phase 2 trial in patients with diabetic kidney disease

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Transplant drugs may help defeat HIV

Transplant drugs may help defeat HIV

Research findings suggest new strategy in fight against HIV infection

Research findings suggest new strategy in fight against HIV infection

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

Protein known to promote cancer appears to give blood vessels strength and shape, researchers report

Protein known to promote cancer appears to give blood vessels strength and shape, researchers report

Novel treatment strategy during transplantation surgery could spare patients from rejection

Novel treatment strategy during transplantation surgery could spare patients from rejection

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

Protein M: an interview with Rajesh Grover, PhD, senior staff scientist, Lerner laboratory, TSRI

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

New discovery has potential to transform heart attack treatments

New discovery has potential to transform heart attack treatments

CU researcher awarded NIH grant to study benefit of allopurino drug in lowering uric acid levels

CU researcher awarded NIH grant to study benefit of allopurino drug in lowering uric acid levels

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Elementary school administrator donates healthy kidney to total stranger

Elementary school administrator donates healthy kidney to total stranger

Paired exchange and incompatible kidney transplant program launched by UAB

Paired exchange and incompatible kidney transplant program launched by UAB

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.